Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-16

Clinical Trial Update: Solifenacin Succinate Versus Fesoterodine A Comparison Trial for Urgency Symptoms [NA]

View source ↗

Summary

This clinical trial compares solifenacin succinate with fesoterodine for urgency symptoms in overactive bladder. The status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Toviaz (fesoterodine fumarate)
  • Vesicare (solifenacin succinate)

Snippet

Sponsor: Rambam Health Care Campus | Conditions: Urinary Bladder, Overactive | NA | Status: UNKNOWN